Lyrica Cr Tablet, Film Coated, Extended Release
Product Images NDC 58151-246

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lyrica Cr (NDC 58151-246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viatris Specialty Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Lyrica Cr Er Tablets 165 mg Bottle Label (Lyrica Cr Er Tablets 165 mg Bottle Label)

Lyrica Cr Er Tablets 165 mg Bottle Label (Lyrica Cr Er Tablets 165 mg Bottle Label)
FDA Label Image

Lyrica Cr Er Tablets 330 mg Bottle Label (Lyrica Cr Er Tablets 330 mg Bottle Label)

Lyrica Cr Er Tablets 330 mg Bottle Label (Lyrica Cr Er Tablets 330 mg Bottle Label)
FDA Label Image

Lyrica Cr Er Tablets 82.5 mg Bottle Label (Lyrica Cr Er Tablets 82.5 mg Bottle Label)

Lyrica Cr Er Tablets 82.5 mg Bottle Label (Lyrica Cr Er Tablets 82.5 mg Bottle Label)
FDA Label Image

Cockcroft And Gault Equation (Image 01)

Cockcroft And Gault Equation (Image 01)
FDA Label Image

Chemical Structure Of Pregabalin (Image 02)

Chemical Structure Of Pregabalin (Image 02)
FDA Label Image

Figure 1 (Image 03)

Figure 1 (Image 03)